Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery
Objectives: To clarify the work done by using AI for identifying the genomic sequences, development of drugs and vaccines for COVID-19 and to recognize the advantages and challenges of using such technology. Methods: A non-systematic review was done. All articles published on Pub-Med, Medline, Googl...
Saved in:
Main Authors: | Sali Abubaker Bagabir (Author), Nahla Khamis Ibrahim (Author), Hala Abubaker Bagabir (Author), Raghdah Hashem Ateeq (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial Intelligence in Oncology Drug Discovery and Development
Published: (2020) -
Artificial Intelligence in Oncology Drug Discovery and Development
Published: (2020) -
Artificial Intelligence in Oncology Drug Discovery and Development
Published: (2020) -
An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases
by: Aftab Alam, et al.
Published: (2022) -
Artificial intelligence for drug discovery: Resources, methods, and applications
by: Wei Chen, et al.
Published: (2023)